These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 234976)

  • 1. Chromatographic heterogeneity of insulin extracted from insulomas.
    Beischer W; Melani F; Keller L; Pfeiffer EF
    J Clin Endocrinol Metab; 1975 Mar; 40(3):393-400. PubMed ID: 234976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-molecular IRI (big, big insulin) in islet cell adenoma.
    Melani F; Beischer W; Keller L; Pfeiffer EF
    Horm Metab Res; 1976; Suppl 6():63-6. PubMed ID: 179931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of high molecular weight insulins in insulinoma patients.
    Permutt M; Biesbroeck J; Chyn R
    J Clin Endocrinol Metab; 1977 Mar; 44(3):536-44. PubMed ID: 190261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide, insulin and proinsulinlike components in diabetic and nondiabetic human pancreas.
    Tasaka Y; Takei M; Hirata Y
    Endocrinol Jpn; 1979 Jun; 26(3):313-8. PubMed ID: 225168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The excretion of proinsulin and insulin in urine.
    Constan L; Mako M; Juhn D; Rubenstein AH
    Diabetologia; 1975 Apr; 11(2):119-23. PubMed ID: 168106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
    Villaume C; Beck B; Pointel JP; Drouin P; Debry G
    Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of pro-insulin, C-peptide, and insulin in nesidioblastosis, focal islet-cell adenomatosis, and genuine insulomas. A correlated radioimmunochemical, immunohistochemical, and ultrastructural investigation with particular regard to the occurrence of argyrophil and pro-insulin immunoreactive cells.
    Kohnert KD; Fält K; Odselius R; Ziegler M; Madsen OD; Grimelius L; Falkmer S
    Diabetes Res; 1988 Aug; 8(4):151-63. PubMed ID: 2853026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conversion of proinsulin into insulin in insulin producing tumors in man].
    Pigareva MI
    Probl Endokrinol (Mosk); 1976; 22(3):15-8. PubMed ID: 180518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of proinsulin and insulin in human insulinoma: preliminary immunohistochemical results.
    Roth J; Kasper M; Stamm B; Häcki WH; Storch MJ; Madsen OD; Klöppel G; Heitz PU
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):287-92. PubMed ID: 2565624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma proinsulin. Comparison of insulin specific protease and gel filtration assays.
    Cresto JC; Lavine RL; Fink G; Recant L
    Diabetes; 1974 Jun; 23(6):505-11. PubMed ID: 4365950
    [No Abstract]   [Full Text] [Related]  

  • 11. Circulating insulin: th proinsulin-like properties of "big" insulin in patients withou islet cell tumors.
    Sherman BM; Gorden P; Roth J; Freychet P
    J Clin Invest; 1971 Apr; 50(4):849-58. PubMed ID: 4323127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia.
    Cohen RM; Given BD; Licinio-Paixao J; Provow SA; Rue PA; Frank BH; Root MA; Polonsky KS; Tager HS; Rubenstein AH
    Metabolism; 1986 Dec; 35(12):1137-46. PubMed ID: 3023795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin and the biosynthesis of insulin.
    Steiner DF
    N Engl J Med; 1969 May; 280(20):1106-13. PubMed ID: 4305118
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism.
    Hayashi M; Floyd JC; Pek S; Fajans SS
    J Clin Endocrinol Metab; 1977 Apr; 44(4):681-94. PubMed ID: 14970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant insulinoma with high ratio of proinsulin-like component inside the tumor--a case report].
    Kanasawa M; Soeda H; Takeshige O; Amano M; Kobayashi T; Kobayashi N; Sugimoto T; Umehara S; Sasa H; Hachiya T
    Nihon Rinsho; 1981 Feb; 39(2):456-62. PubMed ID: 6267337
    [No Abstract]   [Full Text] [Related]  

  • 16. High molecular weight substances with insulin immunoreactivity.
    Villaume C; Beck B; Debry G
    Diabete Metab; 1979 Jun; 5(2):159-65. PubMed ID: 478086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography.
    Knip M
    Horm Metab Res; 1984 Sep; 16(9):487-91. PubMed ID: 6149991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsuppressible insulin-like activity in human serum. 3. Differentiation of two distinct molecules with nonsuppressible ILA.
    Jakob A; Hauri C; Froesch ER
    J Clin Invest; 1968 Dec; 47(12):2678-88. PubMed ID: 5725280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone and insulin in chemically induced pancreatic islet cell tumors in rats.
    Kazumi T; Hirose Y; Ishihara K; Makimura H; Yoshino G; Utsumi M; Baba S
    Horm Metab Res; 1986 Sep; 18(9):584-6. PubMed ID: 3023223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unique form of circulating insulin in human islet cell carcinoma.
    Gorden P; Freychet P; Nankin H
    J Clin Endocrinol Metab; 1971 Dec; 33(6):983-7. PubMed ID: 4332614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.